Preclinical safety evaluation of the aqueous acetone extract of Chinese herbal formula Modified Huo Luo Xiao Ling Dan

Journal of Chinese Integrative Medicine

Volumn 8, Issue 5, 2010, Pages 438-447

  Fan, Arthur Yin ^a,b   Lao, Lixing ^a   Zhang, Rui Xin ^a   Zhou, An Nan ^a,b   Berman, Brian M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b McLean Center for Complementary and Alternative Medicine PLC   (United States)

Author keywords

Acute toxicity tests; Chinese herbal formula; Chronic toxicity tests; Literature investigation; Modified Huo Luo Xiao Ling Dan; Motor function; Rats; Safety; Sub chronic toxicity

Indexed keywords

ACETONE; HERBACEOUS AGENT; HUO LUO XIAO LING DAN EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CHINESE HERB; CONTROLLED STUDY; DRUG SAFETY; FEMALE; MALE; MOTOR PERFORMANCE; NONHUMAN; RAT;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, CHRONIC;

EID: 77952411406     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100507     Document Type: Article

References (44)

1. Bensky D, Gamble A. Chinese herbal medicine: materia medica. Revised ed. Seattle: Eastland Press. 1993: 82-83.
2. World Health Organization. Medicinal plants - guidelines to promote patient safety and plant conservation for a US $ 60 billion industry. Note for the Press 3, 2004; February 10. [2010-03-18]. http://www.who.int/ mediacentre/news/notes/2004/np3/en/
3. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004; (343): 1-19.
4. Sun SM. Valuable prescriptions. Beijing: China Press of Traditional Chinese Medicine. 1998. Chinese. 1998.
5. Wu Q. Golden mirror of medicine. Beijing: People's Medical Publishing House. 2004. Chinese. 2004.
6. Peng HR. Grand dictionary of Chinese medicinal formulas. Beijing: People's Medical Publishing House. 1998. Chinese. 1998.
7. Shennong's pharmacopoeia. Beijing: Academy Press. 2002. Chinese. 2002.
8. Li SZ. Compendium of materia medica. Beijing: People's Medical Publishing House. 2005. Chinese. 2005.
9. Editorial Committee of Chinese Herbal Medicine, State Administration of Traditional Chinese Medicine. Chinese herbal medicine. Shanghai: Shanghai Scientific and Technical Publishers. 1999. 1999
10. Bensky D, Barolet R. Chinese herbal medicine: formulas and strategies. Seattle: Eastland Press. 1990: 329-330.
11. Sharma H. Phytochemical synergism: beyond the active ingredient model. Altern Ther Clin Pract. 1997; 4: 91-96.
12. Zhu YP. Chinese materia medica: chemistry, pharmacology and applications. Amsterdam: Harwood Academic Publishers. 1998: 27-32.
13. China Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. 2000 ed. Beijing: Chemical Industry Press. 2000. Chinese.
14. Zhang XC. Records of tradtional Chinese and Western medicine in combination. Beijing: People's Medical Publishing House. 2006. Chinese. 2006.
15. Yao DS. Modified Huoluo Xiaoling Dan in treatment of arthritis: a report of 123 cases. Hubei Zhong Yi Za Zhi. 1986;(5): 21-22. Chinese. (5): 21-22.
16. Qu YN, Tang BW. The experience in clinical application of Huoluo Xiaoling Dan. Jilin Zhong Yi Yao. 1990; (3): 28. Chinese. 1990; (3): 28.
17. Sun JH, Tao ZG. Huoluo Xiaoling Dan combined with Simiao Yong' an Tang in treatment of thromboangiitis: a report of 17 cases. Shandong Zhong Yi Za Zhi. 1991; 10(5): 24. Chinese. 1991; 10(5): 24.
18. Tang QL. The application of Huoluo Xiaoling Dan in surgery department. Jiangsu Zhong Yi. 1992; ( 2 ): 32-33. Chinese. 1992; (2): 32-33.
19. Wang MY, Yi FS. Modified Huoluo Xiaoling Dan in treating atrophic gastritis: a report of 95 cases. Sichuan Zhong Yi. 1994; (1): 25-26. Chinese. 1994; (1): 25-26.
20. Wu YN, Hua L, Zhang FY, Jin Y, Zhang XH. Conservative therapy of combining laparoscopy and Chinese medicine for ectopic pregnancy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994; 14(10): 583-585. Chinese with abstract in English. 1994; 14 (10): 583-585.
21. Wang TC, Du LH, Wang B, Zhang G. The experimental study of protective effect of Huoluoshugan Capsule on acute hepatic injury. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi. 2002; 10 (1): 27-28. Chinese with abstract in English. 2002; 10(1): 27-28.
22. Wang YC, Ji SY, Wang R. The clinical applications of Huoluo Xiaoling Dan. Zhong Yi Yao Xue Bao. 2002; 30(2): 53. Chinese. 2002; 30(2): 53.
23. Fan AY, Lao L, Zhang RX, Wang LB, Lee DY, Ma ZZ, Zhang WY, Berman B. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation. J Altern Complement Med. 2005; 11(2): 323-331.
24. Lao L, Fan AY, Zhang RX, Zhou A, Ma ZZ, Lee DY, Ren K, Berman B. Anti-hyperalgesic and antiinflammatory effects of the modified Chinese herbal formula Huo Luo Xiao Ling Dan (HLXL) in rats. Am J Chin Med. 2006; 34(5): 833-844. (Pubitemid 44650988)
25. Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudgil KD, Lee DY, Ma ZZ, Zhang WY, Berman BM. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. J Ethnopharmacol. 2005; 101(1-3): 104-109.
26. Zhang RX, Fan AY, Zhou AN, Moudgil KD, Ma ZZ, Lee DY, Fong HH, Berman BM, Lao L. Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats. J Ethnopharmacol. 2009; 121(3): 366-371.
27. World Health Organization. WHO monographs on selected medicinal plants (Vol. I, II, III). Geneva: WHO Press. 1999.
28. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16 (2): 109-110. (Pubitemid 13058546)
29. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry: botanical drug products. 2004. [2010-03-18]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070491.pdf
30. Food and Drug Administration Center for Drug Evaluation and Research ( CDER) . Guidance for industry: single dose acute toxicity testing for pharmaceutics. 1996. [2010-03-18]. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatorylnformation/Guidances/ucm079270.pdf
31. State Administration of Traditional Chinese Medicine. Testing guidelines for safety evaluation of new drug. In: State Administration of Traditional Chinese Medicine. Guidelines for developing new Chinese herbal medicine. 1999. Chinese. 1999.
32. Lao L, Zhang G, Wei F, Berman BM, Ren K. Electro-acupuncture attenuates behavioral hyperalgesia and selectively reduces spinal Fos protein expression in rats with persistent inflammation. Pain. 2001; 2 ( 2 ): 111-117. (Pubitemid 32295075)
33. Shen YJ, Sun RY. The experimental methods of toxicity and safety evaluation on Chinese herbal medicine. In: Chen Q. Technology of research on pharmacology of traditional Chinese medicine. Beijing: People's Medical Publishing House. 2000: 117-118. Chinese. 2000: 117-118.
34. Cao H, Wang ST, Wu LY, Wang XT, Jiang AP. Pharmacological study on Tianxiong (tuber of Aconitum carmichaeli Debx.) , a Chinese drug for reinforcing the kidney yang retail in Hong Kong market. Zhongguo Zhong Yao Za Zhi. 2001; 26 (6): 369-372. Chinese with abstact in English. 2001; 26(6): 369-372.
35. Gad SC. Drug safety evaluation. New York: Wiley-Interscience, John Wiley and Sons, Inc. 2002: 131-504.
36. ShinSS, Jin M, Jung HJ, Kim B, Jeon H, Choi JJ, KimJM, Cho BW, Chung SH, Lee YW, Song YW, Kim S. Suppressive effect of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice. Rheumatology (Oxford). 2003; 42(5): 665-672. (Pubitemid 37220876)
37. Wei F, Zou S, Young A, Dubner R, Ren K. Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats. J Altern Complement Med. 1999; 5 ( 5 ): 429-436. (Pubitemid 29489698)
38. Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Antipsychotics in bipolar disorders. Encephale. 2004; 30(5): 417-424.
39. Paulson GW. Historical comments on tardive dyskinesia: a neurologist's perspective. J Clin Psychiatry. 2005; 66(2): 260-264.
40. Bausell RB, Li YF. Power analysis for experimental research: a practical guide for the biological, medical, and social sciences. Cambridge: Press Syndicate of Cambridge University. 2002.
41. Sigurjónsdóttir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens. 2001; 15(8): 549-552. (Pubitemid 32782619)
42. Hann SK, Park YK, Im S, Byun SW. Angelicainduced phytophotodermatitis. Photodermatol Photoimmunol Photomed. 1991; 8(2): 84-85.
43. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000; 57(13): 1221-1227.
44. Loeb WF, Quimby FW. The clinical chemistry of laboratory animals. 2nd ed. Philadelphia: Taylor & Francis. 1999: 647-692.